| Honey | Type of Cancer Cells | Findings | In Vitro/In Vivo/Clinical Trial | References |
| Acacia | Lung cancer cell (NCI-H460) | Inhibited cell proliferation via cell cycle arrest at G0/G1 phase, stimulation of cytokines and calcium ion, and downregulation of Bcl-2 and p53 gene | In vitro | [244] |
| Human (A375) and murine (B16-F1) melanoma | Induce antiproliferative effect and hyperploid progression through G0/G1 cell cycle arrest and | In vitro | [245] | |
| breast cancer (MCF-7), lung cancer (A549), and colon cancer (HCT-116) | Inhibit cell proliferation with IC50 value of 5.053 μg/mL, 5.382 μg/mL, and 6.728 μg/mL against the breast, colon, and lung cancer cell lines, respectively | In vitro | [246] | |
| HCT116 (colon); MCF7 (breast), and HepG2 (liver) | Inhibit cell proliferation with IC50 ranged 117.99 to 482.65 µg/mL | In vitro | [247] | |
| Breast cancer (MCF-7) | Antiproliferative effect through induction of apoptosis. | In vitro | [248] | |
| Prostate cancer cell line (PC-3) | Promote apoptosis via modulation of G0/G1 phase, pro-inflammatory cytokines, calcium ions secretion and downregulation of prostate-specific antigen. | In vitro | [249] | |
| Gelam | HCT 116 Colorectal Cancer Cells | Inhibit cell proliferation with IC50 of 75 mg/mL and induce apoptosis | In vitro | [250] |
| Colon cancer (HCT 116) | Inhibit cell proliferation with IC50 2.0% v/v after 72 incubation | In vitro | [251] | |
| Human diploid fibroblast | Attenuated radiation-induced cell death by promoting cell cycle progression and inhibiting apoptosis by downregulating ATM, p73, and p16 | In vitro | [252] | |
| HT 29 colon cancer | Inhibit cell proliferation with IC50 of 39.0 mg/mL by inducing apoptosis through DNA damage and suppressing inflammation via reduction in prostaglandin E2. | In vitro | [220] | |
| HT29 Colon cancer | Promote apoptosis via mTOR and Wnt/B-catenin pathway. -downregulated the gene expressions of Akt, mTOR, Raptor, Rictor, β-catenin, Gsk3β, Tcf4 and cyclin D1 while cytochrome C and caspase 3 genes were shown to be upregulated |
In vitro | [253] | |
| HT29 colon cancer | Induce apoptosis by upregulating early pro-apoptotic proteins (caspase 9 and IκB) and downregulating cancer-related genes (KRAS, ERK, AKT, Bcl-xL, NFkB (p65)) | In vitro | [254] | |
| Pineapple | HT 29 colon cancer | Inhibit cell proliferation with IC50 of 85.5 mg/mL by inducing apoptosis through DNA damage and suppressing inflammation via reduction in prostaglandin E2. | In vitro | [220] |
| Kelulut | Cervical cancer (HeLa) | Inhibit cell proliferation with IC50 of 75.76 mg/mL) | In vitro | [255] |
| Lung cancer (A549) | Inhibit cell proliferation at IC50 of 0.62% v/v by inducing cell cycle arrest at G2/M phase | In vitro | [256] | |
| Sprague Dawley rats |
possessed chemo-preventive properties in rats induced with colorectal cancer and it was found to be not toxic to rats. | In vivo | [257] | |
| Tualang | Sprague Dawley rats |
Tualang honey ameliorated breast cancer by increasing the susceptibility of proapoptotic proteins; apoptotic protease activating factor-1 (Apaf-1) interferon-gamma (IFN-γ) interferon gamma receptor-1 (IFNGR1) tumor protein P53 (p53) and decreased the expression of anti-apoptotic proteins; tumour necrosis factor alpha (TNF-α), cyclooxygenase-2 (COX-2) and B-cell lymphoma-extra-large (Bcl-xL). | In vivo | [258] |
| Sprague Dawley rats |
Tualang Honey alleviated breast cancers in rats by reducing cancer cell growth and enhanced histological grading. | In vivo | [259] | |
| Sprague Dawley rats |
Tualang honey showed chemo-preventive properties in oral squamous cell carcinoma-induced rats by suppressing cancer cell proliferation and activity and preserving cellular adhesion. | In vivo | [260] | |
| Sprague Dawley rats |
Tualang Honey alleviated breast carcinogenesis by modulating haematologic, oestrogenic and apoptotic activities in the breast cancer animal model. | In vivo | [261] | |
| Breast cancer (MCF-7 & MDA-MB-231) | Tualang honey promoted apoptotic cell death induced by tamoxifen in breast cancer cell lines. | In vitro | [262] | |
| Breast cancer (MCF-7 & MDA-MB-231) | Tualang honey demonstrated cytotoxic and apoptotic activities against human breast cancer cell lines with the mitochondrial apoptotic pathway’s involvement. Activates caspase-3/7 and -9. | In vitro | [219] | |
| Breast cancer (MCF-7) | Tualang honey was found to be cytotoxic to breast cancer cell line (MCF-7) but protected non-tumorigenic epithelial breast cell line (MCF-10A) from the toxic effects of tamoxifen active metabolite 4-hydroxytamoxifen. | In vitro | [263] | |
| Cervical cancer (HeLa) | Tualang honey demonstrated cytotoxic and apoptotic activities against human cervical cancer cell lines with the mitochondrial apoptotic pathway’s involvement. Activates caspase-3/7 and -9. | In vitro | [219] | |
| Oral squamous cell carcinomas (CRL-1623) | Tualang honey showed an anti-proliferative effect on oral squamous cell carcinoma and osteosarcoma cell lines by inducing early apoptosis. | In vitro | [264] | |
| Human Osteosarcomas (CRL-1543) | ||||
| Acute and chronic myeloid leukaemia (K562 and MV4-11) | Tualang honey demonstrated apoptosis-inducing ability for acute and chronic myeloid leukaemia (K562 and MV4-11) cell lines. | In vitro | [265] | |
| Mouse keratinocyte (PAM212) | Tualang honey protected keratinocytes from ultraviolet radiation-induced inflammation and DNA damage via modulation in early biomarkers of photocarcinogenesis. | In vitro | [266] | |
| Human Keloid fibroblasts (pKHDF) | The methanolic honey extraction has an antiproliferative effect on keloid fibroblasts at 50%, 25%, 12.50% and 6.25% of concentration. | In vitro | [267] | |
| Lung cancer (A549 and H23) | TH inhibited the proliferation of ADC cells in a dose- and time-dependent manner through cell cycle arrest at the G2/M phase. TH induces apoptosis through both intrinsic and extrinsic pathways. | In vitro | [268] | |
| Lung cancer (A549 and H23) | TH exerts anticancer activity through modulation of pertinent cancer-related proteins associated with cell proliferation, apoptosis, and angiogenesis, such as HRAS, HSPB1, TUBA1C, PCNA, ELAVL1, and H3F3A. | In vitro | [269] | |
| Lung cancer (A549) | TH promote apoptosis of A549 cells through alteration of the PI3K/AKT signaling pathway-related proteins. |
In vitro | [270] | |
| Head and neck cancer | Tualang honey improved cancer-related fatigue and quality of life of patients with head and neck cancer post-chemotherapy or radiotherapy. | Human study | [271] | |
| Breast cancer | Combination of Tualang honey and anastrozole showed more improvement in decreasing breast background parenchymal enhancement in patients with breast cancer than anastrozole alone. | Human study | [272] |